Axes Health

design, co-create and implement innovative patient access schemes and HTA strategies for biotech companies

multi-stakeholder engagement: patient advocacy, early dialogues with competent authorities, mock negotiations, follow up of pricing and reimbursement procedure and access negotiations (conventions)

RWE: coordinating the implementation of sustainable disease registries to support appropriate use, new access schemes, pay for performance arrangements and new type of commercial contracting